Regeneron Pharmaceuticals reported $2.86B in Sales Revenues for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Abbvie ABBV:US $ 14583M 1045M
Agenus AGEN:US $ 25.94M 5.68M
Agios Pharmaceuticals AGIO:US $ 5.58M 4.75M
Alimera Sciences ALIM:US $ 14.6M 2.71M
Alnylam Pharmaceuticals ALNY:US $ 224.82M 11.56M
Amgen AMGN:US $ 6594M 356M
Astellas Pharma 4503:JP Y 381791M 77921M
AstraZeneca AZN:LN 10771M 619M
Biogen BIIB:US $ 2589.1M 57.3M
Biomarin Pharmaceutical BMRN:US $ 533.8M 14.44M
Bluebird Bio BLUE:US $ 1.52M 0.43M
Bristol Myers Squibb BMY:US $ 11887M 239M
Eli Lilly And LLY:US $ 6488M 1322M
Esperion Therapeutics ESPR:US $ 18.84M 5K
Gilead Sciences GILD:US $ 6260M 330M
GlaxoSmithKline GSK:LN 6929M 2851M
Intercept Pharmaceuticals ICPT:US $ 71.76M 16.82M
IONIS PHARMACEUT IONS:US $ 141.92M 298.09M
Johnson & Johnson JNJ:US $ 24020M 594M
Kyowa Hakko Kirin 4151:JP Y 97520M 9769M
Merk MRK:US $ 14593M 1308M
Moderna Inc MRNA:US 4.75B 1.32B
Neurocrine Biosciences NBIX:US $ 378.2M 67.6M
Novartis NOVN:VX SF 13085M 271M
Novartis NVS:US $ 13085M 271M
Opthea Ltd OPT:AU 91.22K 336.9K
Pfizer PFE:US $ 27742M 2081M
Puma Biotechnology PBYI:US $ 59.52M 13.78M
Regeneron Pharmaceuticals REGN:US $ 2857.2M 107.9M
Roche Holding ROG:VX 16.44B 474M
Sarepta Therapeutics SRPT:US $ 233.49M 22.66M
Seattle Genetics SGEN:US $ 497.5M 71.04M
Teva Pharmaceutical TEVA:IT 3.79B 125M
Ultragenyx Pharmaceutical RARE:US $ 89.34M 9.41M
United Therapeutics UTHR:US $ 466.9M 5M
Vertex Pharmaceuticals VRTX:US $ 2196.2M 98.7M
YTE INCY:US $ 911.4M 178.16M